Célia H.
- Country
- France
- Department
- NA
Research Overview
- A Phase 1/2 Open-Label Extension Study to Evaluate the Long-Term Safety and Clinical Activity of mRNA-3927 in Participants with Propionic Acidemia
- A Phase 1/2, Global, Open-Label, Extension Study to Evaluate the Long-Term Safety and Clinical Activity of mRNA-3705 in Participants Previously Enrolled in Other Clinical Studies of mRNA-3705.
- A Global, Phase 1/2, Open-label, Dose Optimization Study to Evaluate the Safety, Pharmacodynamics, and Pharmacokinetics of mRNA-3927 in Participants with Propionic Acidemia
Data & Insights
Has run more than one trial at 10 of 14 partner sites.
Specializations
Metabolic Disorders
This investigator specializes in studying Propionic Acidemia, a rare inherited metabolic disorder. Their research focuses on evaluating innovative therapeutic approaches for managing this challenging condition.
- Metabolic Disease Management
- Genetic Metabolic Disorders
- Rare Disease Therapeutics
The investigator's work encompasses safety and efficacy evaluations of potential treatments for patients affected by metabolic conditions.
Clinical Innovation
Their research involves investigating novel therapeutic modalities, including messenger RNA-based treatments. The investigator evaluates treatment responses in patients with inherited metabolic disorders.
- Therapeutic Development
- Treatment Safety Assessment
- Clinical Response Monitoring
The focus includes examining treatment tolerability and measuring clinical outcomes in metabolic disorder patients.
Patient Care
The investigator specializes in medical event management and treatment optimization for patients with metabolic conditions. Their work includes evaluating standard of care practices against new therapeutic approaches.
- Treatment Optimization
- Patient Monitoring
- Clinical Event Management
Their research encompasses comprehensive patient care strategies and therapeutic response assessment.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.